Morgan Stanley’s Concord Medical Services CCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$472 Hold
100
﹤0.01% 7676
2026
Q1
$365 Hold
100
﹤0.01% 7649
2025
Q4
$386 Hold
100
﹤0.01% 7551
2025
Q3
$614 Hold
100
﹤0.01% 7460
2025
Q2
$573 Buy
+100
New +$625 ﹤0.01% 7421
2019
Q2
Sell
-167
Closed -$5K 6650
2019
Q1
$5K Buy
+167
New +$5.32K ﹤0.01% 6317
2017
Q2
Sell
-10
Closed 6590
2017
Q1
$0 Hold
10
﹤0.01% 6575
2016
Q4
$0 Buy
+10
New +$440 ﹤0.01% 6524
2016
Q2
Sell
-120
Closed -$6K 6519
2016
Q1
$6K Sell
120
-259
-68% -$12.2K ﹤0.01% 6241
2015
Q4
$18K Sell
379
-1,296
-77% -$64.2K ﹤0.01% 6062
2015
Q3
$78K Buy
1,675
+482
+40% +$26.2K ﹤0.01% 5538
2015
Q2
$84K Sell
1,193
-447
-27% -$31.1K ﹤0.01% 5671
2015
Q1
$96K Sell
1,640
-346
-17% -$23.7K ﹤0.01% 5546
2014
Q4
$127K Sell
1,986
-489
-20% -$33.9K ﹤0.01% 5448
2014
Q3
$178K Sell
2,475
-393
-14% -$31.3K ﹤0.01% 5202
2014
Q2
$230K Buy
2,868
+2,574
+876% +$185K ﹤0.01% 5079
2014
Q1
$23K Sell
294
-1,198
-80% -$82K ﹤0.01% 5925
2013
Q4
$71K Buy
+1,492
New +$70.1K ﹤0.01% 5474

Other funds holding CCM

Morgan Stanley's CCM Position: Q2 2026 in Review

Morgan Stanley held its Concord Medical Services (CCM) position steady in Q2 2026 at 100 shares worth $472. The position accounts for ﹤0.01% of the portfolio, ranked #7676.

Morgan Stanley first reported a position in CCM in Q4 2013 and has held it in 18 quarters since. The position peaked at $230K in Q2 2014. 7 funds tracked by Wall St. Rank hold CCM as of Q2 2026.

  • Morgan Stanley held 100 shares of Concord Medical Services worth $472 as of Q2 2026.
  • Morgan Stanley left its Concord Medical Services share count unchanged in Q2 2026.
  • Concord Medical Services made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7676 holding.
  • Morgan Stanley first reported a position in Concord Medical Services in Q4 2013 and has held it in 18 quarters since.
  • Morgan Stanley's Concord Medical Services position peaked at $230K in Q2 2014.
  • 7 funds tracked by Wall St. Rank held Concord Medical Services as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.